BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23195018)

  • 21. Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis.
    Tamura S; Osawa S; Ishida N; Miyazu T; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Kosugi I; Furuta T; Sugimoto K
    Sci Rep; 2021 Jul; 11(1):13676. PubMed ID: 34211066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.
    Young PG; Rubin J; Angarone M; Flaherty J; Penugonda S; Stosor V; Ison MG
    Transpl Infect Dis; 2016 Jun; 18(3):390-5. PubMed ID: 27037651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug susceptibility and UL97 gene mutation analysis of cytomegalovirus in recipients of hematopoietic stem cell transplantation].
    Zeng A; Dong D; Cui X; Guo M; Zou D; Fang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):519-22. PubMed ID: 24752100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene].
    Oyarzún MA; Bustos P; González M; Domínguez MI; Aguayo F; Nervi B; Ferres M
    Rev Med Chil; 2010 Apr; 138(4):421-7. PubMed ID: 20668789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.
    Zhou L; Harder TC; Ullmann U; Rautenberg P
    J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
    Recio V; González I; Tarragó D
    Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid semiquantitative real-time PCR for the detection of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.
    Göhring K; Mikeler E; Jahn G; Rohde F; Hamprecht K
    Antivir Ther; 2008; 13(3):461-6. PubMed ID: 18572760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
    Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
    Chong PP; Teiber D; Prokesch BC; Arasaratnam RJ; Peltz M; Drazner MH; Garg S
    Transpl Infect Dis; 2018 Oct; 20(5):e12965. PubMed ID: 29989279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D.
    Iwasenko JM; Scott GM; Rawlinson WD; Keogh A; Mitchell D; Chou S
    J Med Virol; 2009 Mar; 81(3):507-10. PubMed ID: 19152402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.
    Erice A; Borrell N; Li W; Miller WJ; Balfour HH
    J Infect Dis; 1998 Aug; 178(2):531-4. PubMed ID: 9697737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.
    Rose J; Emery VC; Kumar D; Asberg A; Hartmann A; Jardine AG; Bignamini AA; Humar A; Neumann AU
    PLoS Pathog; 2017 Apr; 13(4):e1006299. PubMed ID: 28406982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir.
    Abraham B; Lastere S; Reynes J; Bibollet-Ruche F; Vidal N; Segondy M
    J Clin Virol; 1999 Aug; 13(3):141-8. PubMed ID: 10443790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of a UL97 gene mutation conferring ganciclovir resistance in human cytomegalovirus: prevalence of the D605E polymorphism in Korean immunocompromised patients.
    Sung H; An D; Lee SO; Choi SH; Kim SH; Chi HS; Kim MN
    Ann Clin Lab Sci; 2012; 42(4):429-34. PubMed ID: 23090742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single and multiple mutations in the human cytomegalovirus UL97 gene and their relationship to the enzymatic activity of UL97 kinase for ganciclovir phosphorylation.
    Sanchez Puch SI; Mathet VL; Porta M; Cuestas ML; Oubiña JR; Videla CM; Salomón HE
    Antiviral Res; 2009 Nov; 84(2):194-8. PubMed ID: 19712701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
    Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.